Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CHRS | ADVM | CRDF | ||
| Company | Coherus Bio | Adverum Biotechnologies Inc | Cardiff Oncology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.0900 | 5.75 | 2.50 | ||
| High | 1.1500 | 6.15 | 2.57 | ||
| Low | 1.0500 | 5.69 | 2.44 | ||
| Last | 1.0900 | 6.04 | 2.45 | ||
| Change | -0.0100 | +0.29 | -0.05 | ||
| % Change | -0.91% | +5.04% | -2.00% | ||
| Volume | 2,745,500 | 452,200 | 483,500 | ||
| 20-Day Average Volume | 3,450,250 | 252,595 | 1,095,725 | ||
| Previous Close | 1.1000 | 5.75 | 2.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.8116 | 7.29 | 3.08 | ||
| 20-Day Raw Stochastic | 84.30% | 13.94% | 0.36% | ||
| 20-Day Relative Strength | 60.85% | 35.37% | 42.61% | ||
| Weighted Alpha | -70.97 | -51.54 | -8.07 | ||
| Today's Opinion | 56% Sell | 88% Sell | 40% Sell | ||
| Previous Opinion | 56% Sell | 72% Sell | 32% Sell | ||
| Last Month's Opinion | 100% Sell | 8% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +46.51% since 11/15/24 | -11.95% since 11/15/24 | -5.04% since 11/15/24 | ||
| Low | 0.7350 on 11/18/24 | 5.69 on 11/22/24 | 2.44 on 11/22/24 | ||
| High | 1.1700 on 11/21/24 | 7.73 on 11/18/24 | 2.70 on 11/19/24 | ||
| 1-Month | |||||
| %Chg | +26.54% since 10/22/24 | -25.80% since 10/22/24 | -12.81% since 10/22/24 | ||
| Low | 0.6603 on 11/05/24 | 5.69 on 11/22/24 | 2.44 on 11/22/24 | ||
| High | 1.1700 on 11/21/24 | 8.27 on 10/24/24 | 4.38 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | -17.42% since 08/22/24 | -14.33% since 08/22/24 | +6.99% since 08/22/24 | ||
| Low | 0.6603 on 11/05/24 | 5.69 on 11/22/24 | 2.09 on 09/06/24 | ||
| High | 1.4900 on 08/29/24 | 8.56 on 10/18/24 | 4.38 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | -48.34% since 05/22/24 | -23.54% since 05/22/24 | -29.19% since 05/22/24 | ||
| Low | 0.6603 on 11/05/24 | 5.69 on 11/22/24 | 2.01 on 08/05/24 | ||
| High | 2.1100 on 05/23/24 | 10.14 on 07/18/24 | 4.38 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 125,582 | 125,644 | 125,278 | ||
| Shares Outstanding, K | 115,213 | 20,802 | 51,134 | ||
| Annual Sales | 257,240,000 | 3,600,000 | 490,000 | ||
| Annual Net Income | -237,890,000 | -117,170,000 | -41,440,000 | ||
| Last Quarter Sales | 70,770,000 | 1,000,000 | 170,000 | ||
| Last Quarter Net Income | -10,750,000 | -27,130,000 | -11,860,000 | ||
| 60-Month Beta | 0.69 | 1.02 | 1.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 11/06/24 | -1.30 on 11/04/24 | -0.25 on 11/07/24 | ||
| Latest Earnings Date | 11/06/24 | 11/14/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||